S&P 500   3,087.01 (-0.20%)
DOW   27,691.49 (+0.04%)
QQQ   200.96 (-0.13%)
CGC   20.30 (-5.41%)
BABA   186.71 (-0.24%)
GE   11.35 (-1.48%)
T   39.37 (-0.03%)
F   9.08 (+0.44%)
ACB   3.62 (-4.99%)
PRI   129.23 (-0.37%)
BAC   33.18 (-0.24%)
DIS   136.74 (-0.88%)
S&P 500   3,087.01 (-0.20%)
DOW   27,691.49 (+0.04%)
QQQ   200.96 (-0.13%)
CGC   20.30 (-5.41%)
BABA   186.71 (-0.24%)
GE   11.35 (-1.48%)
T   39.37 (-0.03%)
F   9.08 (+0.44%)
ACB   3.62 (-4.99%)
PRI   129.23 (-0.37%)
BAC   33.18 (-0.24%)
DIS   136.74 (-0.88%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space
(ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 AffimedAcelRx PharmaceuticalsNature's Sunshine ProductsConstellation PharmaceuticalsTAIWAN LIPOSOME/S
SymbolNASDAQ:AFMDNASDAQ:ACRXNASDAQ:NATRNASDAQ:CNSTNASDAQ:TLC
Price Information
Current Price$2.60$1.78$9.33$34.38$5.19
52 Week RangeBuyBuyN/ABuyBuy
Analyst Ratings
Consensus RecommendationBuyBuyN/ABuyBuy
Consensus Price Target$7.39$7.30N/A$41.67$10.67
% Upside from Price Target184.23% upside310.11% upsideN/A21.19% upside105.52% upside
Trade Information
Market Cap$190.91 million$161.25 million$194.95 million$381.40 million$151.13 million
Beta2.912.060.685.32N/A
Average Volume725,3811,502,00414,708143,2233,711
Sales & Book Value
Annual Revenue$28.03 million$2.15 million$364.81 millionN/A$2.04 million
Price / Sales5.7965.770.49N/A81.46
CashflowN/AN/A$0.42 per shareN/AN/A
Price / CashN/AN/A22.06N/AN/A
Book Value$0.76 per share$0.05 per share$6.28 per share$4.04 per share$0.69 per share
Price / Book3.4235.601.49N/A7.52
Profitability
Net Income$-23,000,000.00$-47,150,000.00$-850,000.00$-59,920,000.00$-29,450,000.00
EPS($0.38)($0.81)N/A($5.00)($0.47)
Trailing P/E RatioN/AN/A32.58N/AN/A
Forward P/E Ratio18.57N/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-30.87%-2,327.05%0.82%N/A-390.91%
Return on Equity (ROE)-30.94%N/A4.83%-80.08%-135.07%
Return on Assets (ROA)-12.52%-47.89%2.93%-61.93%-59.13%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.02%N/A0.18%0.44%0.73%
Current Ratio3.48%11.69%1.66%5.85%2.69%
Quick Ratio3.47%11.34%0.97%5.85%2.69%
Ownership Information
Institutional Ownership Percentage51.01%21.41%75.68%65.71%2.11%
Insider Ownership PercentageN/A7.50%20.30%43.70%N/A
Miscellaneous
Employees8,4066190582N/A
Shares Outstanding62.39 million79.44 million19.30 million25.82 million32.02 million
Next Earnings Date11/12/2019 (Confirmed)3/5/2020 (Estimated)3/5/2020 (Estimated)3/12/2020 (Estimated)4/6/2020 (Estimated)
OptionableOptionableOptionableNot OptionableNot OptionableNot Optionable
 AffimedAcelRx PharmaceuticalsNature's Sunshine ProductsConstellation PharmaceuticalsTAIWAN LIPOSOME/S

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel